Skip to main content
Top

International Journal of Clinical Oncology

Issue 4/2005

Content (15 Articles)

REVIEW ARTICLE

Mid-facial reconstruction after maxillectomy

Yuhei Yamamoto

REVIEW ARTICLE

Selective reconstructive options for the anterior skull base

Hideo Nameki, Takashi Kato, Ichirota Nameki, Yasuhiko Ajimi

REVIEW ARTICLE

Functional reconstruction with free flaps following ablationof oropharyngeal cancer

Yoshihiro Kimata, Minoru Sakuraba, Yuzaburo Namba, Ryuichi Hayashi, Satoshi Ebihara

REVIEW ARTICLE

Choice of osseous and osteocutaneous flaps for mandibular reconstruction

Akihiko Takushima, Kiyonori Harii, Hirotaka Asato, Akira Momosawa, Mutsumi Okazaki, Takashi Nakatsuka

REVIEW ARTICLE

Reconstruction of the pharyngoesophagus with voice restoration

Hiroyuki Sakurai, Motohiro Nozaki

ORIGINAL ARTICLE

Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy

Takuhito Tada, Haruyuki Fukuda, Kaoru Matsui, Tomonori Hirashima, Masako Hosono, Yoshie Takada, Yuichi Inoue

ORIGINAL ARTICLE

Performance of outpatient regimen of S-1 in combination with fractional cisplatin for advanced or recurrent gastric cancers: a phase I study

Shouji Shimoyama, Kazuhiro Imamura, Naoki Hiki, Hirokazu Yamaguchi, Ken-ichi Mafune, Michio Kaminishi

ORIGINAL ARTICLE

Feasibility of chemoradiation therapy with protracted infusion of5-fluorouracil for esophageal cancer patients not suitable for cisplatin

Bryan H. Burmeister, Euan T. Walpole, Elizabeth A. Burmeister, Janine Thomas, Damien B. Thomson, Jennifer A. Harvey, B. Mark Smithers, David C. Gotley

ORIGINAL ARTICLE

Acute urinary morbidity following I-125 prostate brachytherapy

Toshio Ohashi, Atsunori Yorozu, Kazuhito Toya, Shiro Saito, Tetsuo Momma

CASE REPORT

Weekly paclitaxel in patients with CAP-resistant advanced or recurrent endometrial carcinoma: a series of four patients

Shoko Akizuki, Noriyuki Katsumata, Yasuhiro Yamanaka, Masashi Andoh, Yasuhiro Fujiwara, Toru Watanabe

CASE REPORT

Meningeal carcinomatosis preceded by a rapid increase in serum CA19-9 levels in a patient with breast cancer

Kazuo Yasumoto, Yutaka Takahashi, Masayoshi Mai, Atsuhiro Kawashima

CASE REPORT

Development of hepatocellular carcinoma following treatment with6-mercaptopurine for ulcerative colitis: investigation of chromosomal aberration by comparative genomic hybridization

Kentaro Nakao, Akira Tsunoda, Yoshinori Shimizu, Koji Takenaka, Koji Morohara, Naoto Suzuki, Katsuo Yamazaki, Takeshi Aoki, Mitsunori Hoshino, Mitsuo Kusano, Eri Kitadai, Toshikazu Kurihara, Yoshiaki Takeuchi, Michio Imawari

CASE REPORT

Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine

Hirofumi Asakura, Hitoshi Takashima, Masahiro Mitani, Reiji Haba, Reiko Seo, Koiku Yokoe, Yoshihiro Toyama, Motoomi Ohkawa

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine